Grabowski HG - Search Results

1

The price of innovation: new estimates of drug development costs.

DiMasi JA, Hansen RW, Grabowski HG. DiMasi JA, et al. Among authors: grabowski hg. J Health Econ. 2003 Mar;22(2):151-85. doi: 10.1016/S0167-6296(02)00126-1. J Health Econ. 2003. PMID: 12606142

2

Should the patent system for new medicines be abolished?

DiMasi JA, Grabowski HG. DiMasi JA, et al. Among authors: grabowski hg. Clin Pharmacol Ther. 2007 Nov;82(5):488-90. doi: 10.1038/sj.clpt.6100393. Clin Pharmacol Ther. 2007. PMID: 17952100 No abstract available.

3

Cost of innovation in the pharmaceutical industry.

DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. Among authors: grabowski hg. J Health Econ. 1991 Jul;10(2):107-42. doi: 10.1016/0167-6296(91)90001-4. J Health Econ. 1991. PMID: 10113009

4

Returns to R&D on new drug introductions in the 1980s.

Grabowski HG, Vernon JM. Grabowski HG, et al. J Health Econ. 1994 Dec;13(4):383-406. doi: 10.1016/0167-6296(94)90010-8. J Health Econ. 1994. PMID: 10140531 Review.

5

Public policy and pharmaceutical innovation.

Grabowski HG. Grabowski HG. Health Care Financ Rev. 1982 Sep;4(1):75-87. Health Care Financ Rev. 1982. PMID: 10309721 Free PMC article.

6

The distribution of sales revenues from pharmaceutical innovation.

Grabowski HG, Vernon J. Grabowski HG, et al. Pharmacoeconomics. 2000;18 Suppl 1:21-32. doi: 10.2165/00019053-200018001-00005. Pharmacoeconomics. 2000. PMID: 11151306

7

Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. Among authors: grabowski hg. Pharmacoeconomics. 1995 Feb;7(2):152-69. doi: 10.2165/00019053-199507020-00007. Pharmacoeconomics. 1995. PMID: 10155302

8

Updated trends in US brand-name and generic drug competition.

Grabowski H, Long G, Mortimer R, Boyo A. Grabowski H, et al. J Med Econ. 2016 Sep;19(9):836-44. doi: 10.1080/13696998.2016.1176578. Epub 2016 Apr 20. J Med Econ. 2016. PMID: 27064194

9

Recent trends in brand-name and generic drug competition.

Grabowski H, Long G, Mortimer R. Grabowski H, et al. J Med Econ. 2014 Mar;17(3):207-14. doi: 10.3111/13696998.2013.873723. Epub 2013 Dec 23. J Med Econ. 2014. PMID: 24320785

10

Returns on research and development for 1990s new drug introductions.

Grabowski H, Vernon J, DiMasi JA. Grabowski H, et al. Pharmacoeconomics. 2002;20 Suppl 3:11-29. doi: 10.2165/00019053-200220003-00002. Pharmacoeconomics. 2002. PMID: 12457422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results